Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

18.09
Delayed Data
As of Nov 27
 +0.22 / +1.23%
Today’s Change
12.33
Today|||52-Week Range
22.69
-6.22%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$872.2M

Company Description

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Contact Information

Amphastar Pharmaceuticals, Inc.
11570 6th Street
Rancho Cucamonga California 91730
P:(800) 423-4136
Investor Relations:

Employees

Shareholders

Mutual fund holders37.90%
Individual stakeholders24.69%
Other institutional18.16%

Top Executives

Zi Ping LuoChairman, COO & Chief Scientist
Yong Feng ZhangPresident, Chief Executive & Scientific Officer
William J. PetersChief Financial Officer, Treasurer & Senior VP
Rong ZhouExecutive Vice President-Production Center
Jacob LiawatidewiSecretary, SVP-Corporate Administration Centre